DYSLIPIDAEMIA
Clinical trials for DYSLIPIDAEMIA explained in plain language.
Never miss a new study
Get alerted when new DYSLIPIDAEMIA trials appear
Sign up with your email to follow new studies for DYSLIPIDAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to crush bad cholesterol in High-Risk patients
Disease control Recruiting nowThis study is testing whether a new oral drug called AZD0780, when taken alongside the common cholesterol medication rosuvastatin, can lower 'bad' LDL cholesterol more effectively than rosuvastatin alone. It will involve about 76 adult participants in Russia who have high cholest…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New pill aims to tackle stubborn cholesterol
Disease control Recruiting nowThis study is testing a new oral medication called AZD0780 to see if it can safely and effectively lower 'bad' cholesterol (LDL-C) in people with dyslipidemia. The trial will involve about 360 adults in China, some already on standard cholesterol treatments and some not. Particip…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE2, PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC